Clinical trial

Safety & Efficacy of Omega-3 Fish Oil in Overweight Children & Adolescents

NCT00447291 · Children's Heart Center, Industry · Terminated

Key facts

NCT number NCT00447291
Title Safety & Efficacy of Omega-3 Fish Oil in Overweight Children & Adolescents
Official title Evaluation of the Safety and Efficacy of Omega-3 Fish Oil Dietary Supplementation in Biometric Measurement, Lipid Profile, Serum Markers for Inflammation, and Insulin Resistance in Overweight Children and Adolescents
Lead sponsor Children's Heart Center, Industry
Collaborators Zone Laboratories, Inc. Industry
Status Terminated
Phase Phase 3
Study type Interventional
Conditions Overweight, Obesity
Intervention type Behavioral, Drug
Interventions Supplement: Omega-3 Fish Oil, Multi-Disciplinary Nutrition & Exercise program
Enrollment 60
Start date Dec 1, 2006
Primary completion Mar 1, 2010
Completion Jul 1, 2010
First posted Mar 14, 2007
Last update posted Jan 27, 2011
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies